| Host: |
Rabbit |
| Applications: |
IHC/IF/WB/ELISA |
| Reactivity: |
Human/Rat/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Cytosolic 5 nucleotidase 1B (171-220 aa) is suitable for use in Immunohistochemistry, Immunofluorescence, Western Blot and ELISA research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000IHC 1:100-1:300IF 1:200-1:1000ELISA 1:20000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
NT5C1B |
| Gene ID: |
100526794/93034 |
| Uniprot ID: |
5NT1B_HUMAN |
| Immunogen Region: |
171-220 aa |
| Specificity: |
AIRP Polyclonal Antibody detects endogenous levels of AIRP protein. |
| Immunogen: |
The antiserum was produced against synthesized peptide derived from the human NT5C1B at the amino acid range 171-220 |
| Function | Catalyzes the hydrolysis of nucleotide monophosphates, releasing inorganic phosphate and the corresponding nucleoside, AMP is the major substrate. |
| Protein Name | Cytosolic 5'-Nucleotidase 1bCn1bAutoimmune Infertility-Related ProteinCytosolic 5'-Nucleotidase IbCn-Ib |
| Database Links | Reactome: R-HSA-74259 |
| Cellular Localisation | Cytoplasm |
| Alternative Antibody Names | Anti-Cytosolic 5'-Nucleotidase 1b antibodyAnti-Cn1b antibodyAnti-Autoimmune Infertility-Related Protein antibodyAnti-Cytosolic 5'-Nucleotidase Ib antibodyAnti-Cn-Ib antibodyAnti-NT5C1B antibodyAnti-AIRP antibodyAnti-FKSG85 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
